Treatment of hairy cell leukemia with 2-chlorodeoxyadenosine via the Group C protocol mechanism of the National Cancer Institute: a report of 979 patients.

Nonparametric Estimation from Incomplete Observations

1992 • 45,923 citations

Applied Regression Analysis

2005 • 18,630 citations

Lasting Remissions in Hairy-Cell Leukemia Induced by a Single Infusion of 2-Chlorodeoxyadenosine

1990 • 521 citations

Cladribine (2-chlorodeoxyadenosine)

1992 • 338 citations

Randomized comparison of pentostatin versus interferon alfa-2a in previously untreated patients with hairy cell leukemia: an intergroup study.

1995 • 268 citations

Remissions in Hairy-Cell Leukemia with Pentostatin (2′-Deoxycoformycin)

1987 • 265 citations

2-chlorodeoxyadenosine induces durable remissions and prolonged suppression of CD4+ lymphocyte counts in patients with hairy cell leukemia

1994 • 211 citations

Neurotoxicity of purine analogs: a review.

1994 • 190 citations

Treatment of hairy cell leukemia with 2-chlorodeoxyadenosine (2-CdA)

1992 • 154 citations

Treatment of hairy-cell leukemia with cladribine: response, toxicity, and long-term follow-up.

1997 • 134 citations

Second cancer risk in hairy cell leukemia: analysis of 350 patients.

1997 • 117 citations

Low-dose deoxycoformycin in the treatment of hairy cell leukemia

1986 • 107 citations

Pentostatin induces durable remissions in hairy cell leukemia.

1991 • 106 citations

Subcutaneous injections of 2-chlorodeoxyadenosine for symptomatic hairy cell leukemia.

1995 • 104 citations

Relapse of hairy cell leukemia after 2-chlorodeoxyadenosine: long-term follow-up of the Northwestern University experience

1996 • 103 citations

Minimal residual disease may predict bone marrow relapse in patients with hairy cell leukemia treated with 2-chlorodeoxyadenosine

1996 • 91 citations

Therapeutic and neurotoxic effects of 2-chlorodeoxyadenosine in adults with acute myeloid leukemia

1994 • 83 citations

Oral cladribine as primary therapy for patients with B-cell chronic lymphocytic leukemia.

1996 • 81 citations

High incidence of infections after 2-chlorodeoxyadenosine (2-CDA) therapy in patients with malignant lymphomas and chronic and acute leukaemias

1994 • 74 citations

Immunomorphologic analysis of bone marrow biopsies after treatment with 2-chlorodeoxyadenosine for hairy cell leukemia

1994 • 72 citations

Detection of minimal residual disease by immunostaining of bone marrow biopsies after 2-chlorodeoxyadenosine for hairy cell leukemia

1993 • 67 citations

A single course of 2-chloro-deoxyadenosine does not eradicate leukemic cells in hairy cell leukemia patients in complete remission.

1994 • 54 citations

Tumor Lysis Syndrome Following Treatment with 2-Chlorodeoxyadenosine for Refractory Chronic Lymphocytic Leukemia

1993 • 36 citations

Interferon treatment for hairy cell leukemia: an update on a cohort of 69 patients treated from 1983-1986.

1992 • 24 citations

Myelodysplasia occurring after fludarabine treatment for chronic lymphocytic leukaemia

1997 • 21 citations